EGF Theramed Health (XCNQ:TMED) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is EGF Theramed Health LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. EGF Theramed Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

EGF Theramed Health's long-term debt to total assets ratio declined from Mar. 2023 (4.75) to Mar. 2024 (0.00). It may suggest that EGF Theramed Health is progressively becoming less dependent on debt to grow their business.

EGF Theramed Health LT-Debt-to-Total-Asset Historical Data

The historical data trend for EGF Theramed Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGF Theramed Health LT-Debt-to-Total-Asset Chart

EGF Theramed Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

4.69

4.74

EGF Theramed Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															4.75	4.74	-	-	-

EGF Theramed Health LT-Debt-to-Total-Asset Calculation

EGF Theramed Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2023 is calculated as

LT Debt to Total Assets (A: Jun. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2023 )	/	Total Assets (A: Jun. 2023 )
	=	0.92	/	0.194
	=

EGF Theramed Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	0	/	0.199
	=

EGF Theramed Health (XCNQ:TMED) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

EGF Theramed Health LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of EGF Theramed Health's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

EGF Theramed Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EGF Theramed Health Corp (XCNQ:TMED) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

EVAHF:USA AUH:Germany

Address

609 Granville Street, Suite 1600, P.O. Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3

Website

https://www.egftheramedhealth.com

EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. The company explores many other medical areas including weight loss, skincare and heart disease.

Executives

Jatinder Dhaliwal

Director